| Abnormalities of lipid metabolism and methods of their correction in patients with glomerulonephritis. | |
| | |
MedLine Citation:
|
PMID: 6535784 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The results of integrated estimations of a complex of lipid indices are presented. Their abnormalities are considered to be atherosclerosis risk factors in the evolution of glomerulonephritis and its different variants, types and stages. The quantitative and qualitative peculiarities of the indicated abnormalities are revealed, in particular, their major expressiveness in chronic form, nephrotic variant and in the stage of renal failure. Two aspects of correction of actual abnormalities are singled out: 1. indirect, i.e. treatment of the renal pathologic process with preparation of pathogenetic therapy (glucocorticoids, indomethacin), and 2. direct, i.e. with medications exerting a corrective influence on lipid metabolism (clofibrate, nicotinic acid, curantil). The selection of corrective methods is determined by the stage of disease and by the character of the changes in lipid metabolism. |
| | |
Authors:
|
L A Pyrig; Melman NYa; N M Petrun; G G Nikulina; N R Gorelova |
Related Documents
:
|
20640114 - Anaesthesia for renal transplantation: an update. 19438394 - Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment a... 23165494 - Standard treatment of acquired saa in adult patients 18-40 years old with an hla-identi... 15715124 - The developing role of the renal diabetes nurse. 19459804 - Similar outcomes with different rates of delayed graft function may reflect center prac... 6742204 - Renal function in rats chronically exposed to high altitude. |
Publication Detail:
|
Type: Comparative Study; Journal Article |
Journal Detail:
|
Title: International urology and nephrology Volume: 16 ISSN: 0301-1623 ISO Abbreviation: Int Urol Nephrol Publication Date: 1984 |
Date Detail:
|
Created Date: 1985-08-13 Completed Date: 1985-08-13 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0262521 Medline TA: Int Urol Nephrol Country: HUNGARY |
Other Details:
|
Languages: eng Pagination: 361-7 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Arteriosclerosis / etiology, prevention & control Clofibrate / therapeutic use Dipyridamole / therapeutic use Female Glomerulonephritis / complications*, drug therapy, metabolism Humans Hyperlipidemias / drug therapy, etiology*, metabolism Lipids / blood* Male Middle Aged Niacin / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Lipids; 58-32-2/Dipyridamole; 59-67-6/Niacin; 637-07-0/Clofibrate |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Haemoperfusion in the treatment of chronic renal failure in patients on haemodialysis.
Next Document: Production and characterization of a murine monoclonal antibody recognizing a shared mycobacterial p...